China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-11-30 01:30 Cardinal Health Buys Majority Share of Guangzhou Baiji Xinte Drug Store 2013-11-29 01:30 Nanjing Frontier Biotech Begins China Phase III Trial of HIV Treatment 2013-11-28 01:30 BioPacific to Make Cross-Border Angel Investments in Life Sciences and more... 2013-11-27 01:30 SIMM and Crown Bioscience to Collaborate on Cancer Center in China and more... 2013-11-26 01:30 Guangzhou Pharma to Set Up JV with Dr. Ferid Murad, a Nobel Winner 2013-11-24 01:30 Week in Review: Golden Meditech to Raise Capital from Shareholders 2013-11-23 01:30 China Researchers Develop Novel Cancer Biomarker 2013-11-22 01:30 Gentris Opens Pharmacogenomics Lab in Shanghai 2013-11-21 01:30 Golden Meditech to Raise $32 Million from Existing Investors and more... 2013-11-20 01:30 China Resources to Distribute Imaging Agent for Mallinckrodt 2013-11-19 01:30 Catalent Opens Shanghai Clinical Trial Supply Center 2013-11-17 01:30 Week in Review: BeiGene Out-Licenses Novel Cancer Drug to Merck Serono 2013-11-16 01:30 CFDA: China Pharma Output Grows, but Profits Lag and more... 2013-11-15 01:30 Lilly Will Invest $350 Million in China Diabetes Cartridge Facility 2013-11-14 01:30 BeiGene Out-Licenses Second Molecule to Merck Serono in $232 Million Deal and more... 2013-11-13 01:30 Medifocus Forms China JV to Speed Development of its Medical Devices 2013-11-12 01:30 PW Medtech Completes $180 Million Hong Kong IPO and more... 2013-11-10 01:30 Week in Review: Lorem Vascular Signs $531 Million Deal with Cytori 2013-11-09 01:30 China's ZDG Options Canadian Medical Devices in a Potential Blockbuster Deal and more... 2013-11-08 01:30 China New Enterprise Invests Additional $25 Million in Shanghai Fudan-Zhangjiang and more... 2013-11-07 01:30 Lorem Vascular Pays $531 Million for Rights to Cytori Stem Cell System in China 2013-11-06 01:30 Hansen Pharma Buys 80% Interest in Yongzitang Pharma for $45 Million and more... 2013-11-05 01:30 WuXi PharmaTech In-Licenses Cancer Models from the Mayo Clinic 2013-11-03 01:30 Week in Review: Three China In-Licensings and One Nixed Intra-China Deal 2013-11-02 01:30 Sichuan Kelun's Purchase of 20% Stake in Lijun Pharma is Off and more... 2013-11-01 01:30 Sanofi's Q3 China Revenues Increase at Slower 5% Rate and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC